These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31087195)

  • 21. Patterns of brain atrophy in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    Messina D; Cerasa A; Condino F; Arabia G; Novellino F; Nicoletti G; Salsone M; Morelli M; Lanza PL; Quattrone A
    Parkinsonism Relat Disord; 2011 Mar; 17(3):172-6. PubMed ID: 21236720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The odor stick identification test for Japanese differentiates Parkinson's disease from multiple system atrophy and progressive supra nuclear palsy.
    Suzuki M; Hashimoto M; Yoshioka M; Murakami M; Kawasaki K; Urashima M
    BMC Neurol; 2011 Dec; 11():157. PubMed ID: 22192419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.
    Bhidayasiri R; Sringean J; Reich SG; Colosimo C
    Parkinsonism Relat Disord; 2019 Feb; 59():82-92. PubMed ID: 30409560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
    Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
    Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation of parkinsonian syndromes according to differences in executive functions.
    Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
    J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review.
    Jesse S; Steinacker P; Lehnert S; Gillardon F; Hengerer B; Otto M
    CNS Neurosci Ther; 2009; 15(2):157-82. PubMed ID: 19298613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.
    Seppi K; Schocke MF; Esterhammer R; Kremser C; Brenneis C; Mueller J; Boesch S; Jaschke W; Poewe W; Wenning GK
    Neurology; 2003 Mar; 60(6):922-7. PubMed ID: 12654954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep disturbances and brain MRI morphometry in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy - a comparative study.
    Gama RL; Távora DG; Bomfim RC; Silva CE; de Bruin VM; de Bruin PF
    Parkinsonism Relat Disord; 2010 May; 16(4):275-9. PubMed ID: 20185356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkinson's disease and look-alikes.
    Khadilkar SV
    J Assoc Physicians India; 2010 Feb; 58():75. PubMed ID: 20653146
    [No Abstract]   [Full Text] [Related]  

  • 31. Individual voxel-based subtype prediction can differentiate progressive supranuclear palsy from idiopathic Parkinson syndrome and healthy controls.
    Focke NK; Helms G; Scheewe S; Pantel PM; Bachmann CG; Dechent P; Ebentheuer J; Mohr A; Paulus W; Trenkwalder C
    Hum Brain Mapp; 2011 Nov; 32(11):1905-15. PubMed ID: 21246668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy.
    Jia P; Zhang J; Han J; Ji Y
    Brain Behav; 2022 Dec; 12(12):e2827. PubMed ID: 36409061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
    Avenali M; Tassorelli C; De Icco R; Perrotta A; Serrao M; Fresia M; Pacchetti C; Sandrini G
    Clin Neurophysiol; 2017 Oct; 128(10):1978-1984. PubMed ID: 28829981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The contribution of cerebellar proton magnetic resonance spectroscopy in the differential diagnosis among parkinsonian syndromes.
    Zanigni S; Testa C; Calandra-Buonaura G; Sambati L; Guarino M; Gabellini A; Evangelisti S; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2015 Aug; 21(8):929-37. PubMed ID: 26077167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic value of blink reflex in multisystem atrophy, progressive supranuclear palsy and Parkinson disease.
    Szmidt-Salkowska E; Gawel M; Jamrozik Z; Salkowska-Wanat J; Gawel D; Kaminska A
    Neurol Neurochir Pol; 2016; 50(5):336-41. PubMed ID: 27591058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orofacial apraxia in corticobasal degeneration, progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
    Ozsancak C; Auzou P; Dujardin K; Quinn N; Destée A
    J Neurol; 2004 Nov; 251(11):1317-23. PubMed ID: 15592726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Card-type Odor Identification Test for Japanese Patients with Parkinson's Disease and Related Disorders.
    Watanabe Y; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Uchiyama T; Kadowaki T; Matsubara T; Hirata K
    Intern Med; 2017 Nov; 56(21):2871-2878. PubMed ID: 28943542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
    Tripathi M; Tang CC; Feigin A; De Lucia I; Nazem A; Dhawan V; Eidelberg D
    J Nucl Med; 2016 Jan; 57(1):60-6. PubMed ID: 26449840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B; Rosengren L; Karlsson JE; Johnels B
    Mov Disord; 1998 Jan; 13(1):70-7. PubMed ID: 9452329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.